• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固有免疫基因多态性与基于树突状细胞的 HIV 免疫治疗患者反应。

Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.

机构信息

Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco, Recife, Brazil; Genetic Service, IRCCS Burlo Garofolo and University of Trieste, Italy.

Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco, Recife, Brazil.

出版信息

Vaccine. 2010 Mar 2;28(10):2201-2206. doi: 10.1016/j.vaccine.2009.12.056. Epub 2010 Jan 5.

DOI:10.1016/j.vaccine.2009.12.056
PMID:20056178
Abstract

Dendritic cells (DCs)-based vaccine was demonstrated to increase HIV specific cellular immune response; however, in some HIV-infected patients, the response to the vaccine resulted to be not effective. In order to understand if the outcome of the vaccination may be influenced by the host's genome and natural immunity, we studied the innate immune genome of HIV-infected patients previously vaccinated with DCs. We identified 15 SNPs potentially associated with the response to the immuno-treatment and two SNPs significantly associated with the modulation of the response to the DC vaccine: MBL2 rs10824792 and NOS1 rs693534. These two SNPs were also studied in different ethnic groups (Brazilians, African and Caucasian) of HIV-infected, exposed uninfected and unexposed uninfected subjects. The HIV positive Caucasian patients were also characterized by different disease progressions. Our findings suggest that, independently and/or in addition to other variables, the host's genome could significantly contribute to the modulation of the response to the DC vaccine.

摘要

树突状细胞(DC)疫苗已被证明可增强 HIV 特异性细胞免疫应答;然而,在一些 HIV 感染患者中,疫苗的应答效果并不理想。为了了解疫苗接种的结果是否可能受到宿主基因组和天然免疫的影响,我们研究了先前接受 DC 疫苗免疫的 HIV 感染患者的固有免疫基因组。我们鉴定了 15 个可能与免疫治疗应答相关的单核苷酸多态性(SNP)和两个与 DC 疫苗应答调节显著相关的 SNP:MBL2 rs10824792 和 NOS1 rs693534。这两个 SNP 还在不同种族(巴西人、非洲人和高加索人)的 HIV 感染、暴露未感染和未暴露未感染的受试者中进行了研究。HIV 阳性的高加索患者也表现出不同的疾病进展。我们的研究结果表明,宿主基因组可能独立地(或与其他变量一起)显著影响 DC 疫苗的应答调节。

相似文献

1
Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.固有免疫基因多态性与基于树突状细胞的 HIV 免疫治疗患者反应。
Vaccine. 2010 Mar 2;28(10):2201-2206. doi: 10.1016/j.vaccine.2009.12.056. Epub 2010 Jan 5.
2
Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.宿主遗传学影响基于树突状细胞的 HIV 免疫疗法的效果。
Hum Vaccin Immunother. 2018;14(8):1995-2002. doi: 10.1080/21645515.2018.1463942. Epub 2018 May 17.
3
Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy.对两组接受基于树突状细胞免疫疗法治疗的HIV感染患者进行全基因组扫描。
Immunol Res. 2016 Dec;64(5-6):1207-1215. doi: 10.1007/s12026-016-8875-x.
4
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.在 HIV-1 感染中基于树突状细胞的治疗性疫苗接种的挑战 HIV-1 树突状细胞疫苗临床试验研讨会
Vaccine. 2011 Sep 2;29(38):6454-63. doi: 10.1016/j.vaccine.2011.07.043. Epub 2011 Jul 23.
5
Dendritic cell based vaccines for HIV infection: the way ahead.树突状细胞疫苗治疗 HIV 感染:未来之路。
Hum Vaccin Immunother. 2013 Nov;9(11):2445-52. doi: 10.4161/hv.25876. Epub 2013 Aug 2.
6
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.接种疫苗和中断抗逆转录病毒治疗后的HIV-1储存库动态与树突状细胞疫苗诱导的T细胞反应相关。
J Virol. 2015 Sep;89(18):9189-99. doi: 10.1128/JVI.01062-15. Epub 2015 Jun 24.
7
DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift.HIV-1感染中的树突状细胞免疫疗法可引起血液转录组的重大转变。
Vaccine. 2015 Jun 9;33(25):2922-9. doi: 10.1016/j.vaccine.2015.04.047. Epub 2015 Apr 24.
8
Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1.宿主基因组中的HIV限制因子可调节针对HIV-1的基于树突状细胞治疗的反应。
Hum Vaccin Immunother. 2014;10(2):512-8. doi: 10.4161/hv.27125. Epub 2013 Nov 15.
9
Dendritic cells as a conduit to improve HIV vaccines.树突状细胞作为改进HIV疫苗的一种途径。
Curr Mol Med. 2003 May;3(3):229-42. doi: 10.2174/1566524033479870.
10
Mannose-binding lectin and MBL-associated serine protease-2 gene polymorphisms in a Brazilian population from Rio de Janeiro.巴西里约热内卢人群甘露聚糖结合凝集素和 MBL 相关丝氨酸蛋白酶-2 基因多态性。
Int J Immunogenet. 2012 Feb;39(1):32-8. doi: 10.1111/j.1744-313X.2011.01052.x. Epub 2011 Oct 29.

引用本文的文献

1
Immune mechanisms behind prostate cancer in men of African ancestry: A review.非洲裔男性前列腺癌背后的免疫机制:综述。
Prostate. 2022 Jun;82(8):883-893. doi: 10.1002/pros.24333. Epub 2022 Mar 7.
2
Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?基于树突状细胞的免疫疗法治疗 HIV:如何改进这种策略?
Front Immunol. 2018 Dec 18;9:2993. doi: 10.3389/fimmu.2018.02993. eCollection 2018.
3
Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.宿主遗传学影响基于树突状细胞的 HIV 免疫疗法的效果。
Hum Vaccin Immunother. 2018;14(8):1995-2002. doi: 10.1080/21645515.2018.1463942. Epub 2018 May 17.
4
Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis.基于树突状细胞的抗HIV免疫疗法:距离成功还有多远?一项系统评价与荟萃分析
Int J Mol Sci. 2016 Nov 26;17(12):1985. doi: 10.3390/ijms17121985.
5
Exome analysis of HIV patients submitted to dendritic cells therapeutic vaccine reveals an association of CNOT1 gene with response to the treatment.对接受树突状细胞治疗性疫苗的HIV患者进行外显子组分析发现,CNOT1基因与治疗反应相关。
J Int AIDS Soc. 2014 Jan 10;17(1):18938. doi: 10.7448/IAS.17.1.18938. eCollection 2014.
6
Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1.宿主基因组中的HIV限制因子可调节针对HIV-1的基于树突状细胞治疗的反应。
Hum Vaccin Immunother. 2014;10(2):512-8. doi: 10.4161/hv.27125. Epub 2013 Nov 15.